Annual RSSL QP Symposium 2026

RSSL invites you to attend the 2026 Annual QP Symposium:

The Modern QP: Novel Therapies, New Regulations, New Expectations

29 September 2026
Royal Society of Chemistry, Burlington House, London
Cost - £365 + VAT

 

The scope of a Qualified Person has long revolved around classic formulation types. The market is changing, and fast. Novel, complex and specialist formulations are becoming the norm and the regulations are following closely behind. We have assembled a panel of experts working across the new fields to deliver CPD and insight into the formulations and regulations now reshaping the QP role.

 

Spaces are limited, please do book early to avoid disappointment.

 

Qualified Person in a manufacturing setting

Why attend?

Understand

new formulation categories, from IMPs and Specials to ATMPs and Radiopharmaceuticals

Learn

the regulatory changes shaping the QP role, including the recent clinical trials amendment regulations

Build

your CPD portfolio with knowledge that is future-proof

Network

with the QP community and discuss shared challenges

Who should attend?

QP trainees

at any stage of the journey, looking to confidently answer VIVA questions on unfamiliar or diverse products

 

Sponsors

supporting trainee QPs, seeking to strengthen application success

Experienced QP's

wanting to broaden their knowledge and CPD in a shifting manufacturing environment

 

Internal QP's

whose organisations are expanding into new formulation types

 

Programme

 

The QP conference is a full-day event featuring a series of invited talks, panel sessions, interactive workshops and networking opportunities.

 

Time Item
08:45 Registration and Coffee
09:15 Welcome and Introduction to RSSL
Emily Ness
09:30 Role and Duties of a QP in a Diverse and Changing Manufacturing Environment
Peter Deegan
10:00 Investigational Medicinal Products (IMP) Clinical Supply
Speaker TBC
10:20 Specials Manufacture
Speaker TBC
10:40 Inhalation Devices
Steve Nolan
11:00 Coffee and Networking
11:20 Workshop: QP Scenarios (Sessions 2-4)
11:45 Cell and Gene Therapy/Biologics
Rebecca Rutter
12:05 Decentralised Manufacturing Model
Peter Deegan and Ben Broadbent
12:45 Lunch and Networking
13:45 The Progression and Pitfalls of AI in Pharma
Martin Lush
14:05 Radiopharmaceuticals
TBC
14:40 ICH E6 Revision 3: Clinical Trial Guidance Updates
Peter Deegan
15:00 Coffee and Networking
15:20 Interactive Workshop: Novel Formulation Knowledge
Peter Deegan and Presenters
16:00 Regulatory Update
MHRA Speaker TBC
16:20 Closing Remarks and Q&A
16:30 End of Conference

 

For further information, contact the RSSL Training Team trainingsales@rssl.com | 0118 918 4076 or  book your place here.